Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial

Clin Exp Hypertens. 2007 Aug;29(6):383-94. doi: 10.1080/10641960701578378.

Abstract

In the setting of a six-month, open-label clinical trial, 141 consecutively enrolled, hypertensive, overweight patients were randomized to the oral ingestion of psyllium powder or guar gum 3.5 gr t.i.d., to be taken 20 min before the main two meals, or to standard diet. Both fibers improved significantly BMI, FPG, FPI, HOMA Index, HbA1c, LDL-C, and ApoB. Psyllium supplementation only exerted a significant improvement in plasma TG concentration, in SBP and DBP. In our study, six-month supplementation with psyllium fiber, but not with guar fiber nor standard diet, appears to significantly reduce both SBP and DBP in hypertensive overweight subjects.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anti-Obesity Agents / adverse effects
  • Anti-Obesity Agents / therapeutic use
  • Body Mass Index
  • Cathartics / adverse effects
  • Cathartics / therapeutic use
  • Dietary Fiber / adverse effects
  • Dietary Fiber / therapeutic use
  • Galactans / adverse effects
  • Galactans / therapeutic use*
  • Humans
  • Hypertension / diet therapy*
  • Hypertension / physiopathology
  • Lipid Metabolism / drug effects
  • Mannans / adverse effects
  • Mannans / therapeutic use*
  • Matched-Pair Analysis
  • Middle Aged
  • Overweight
  • Plant Gums / adverse effects
  • Plant Gums / therapeutic use*
  • Psyllium / adverse effects
  • Psyllium / therapeutic use*

Substances

  • Anti-Obesity Agents
  • Cathartics
  • Dietary Fiber
  • Galactans
  • Mannans
  • Plant Gums
  • Psyllium
  • guar gum